Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 14/20 | 0.61 |
| ▸ | CA2 | P00918 | 14/20 | 0.61 |
| ▸ | CA9 | Q16790 | 12/20 | 0.61 |
| ▸ | CA12 | O43570 | 4/20 | 0.61 |
| ▸ | CA7 | P43166 | 4/20 | 0.61 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.61 |
| ▸ | CA3 | P07451 | 3/20 | 0.61 |
| ▸ | CA4 | P22748 | 3/20 | 0.61 |
| ▸ | CA6 | P23280 | 3/20 | 0.61 |
| ▸ | CA5A | P35218 | 3/20 | 0.61 |
| ▸ | CA5B | Q9Y2D0 | 3/20 | 0.61 |
| ▸ | RECQL | P46063 | 2/20 | 0.59 |
| ▸ | TSHR | P16473 | 2/20 | 0.59 |
| ▸ | GLA | P06280 | 1/20 | 0.59 |
| ▸ | HPGD | P15428 | 1/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.59 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.59 |
| ▸ | BLM | P54132 | 1/20 | 0.59 |
| ▸ | NAAA | Q02083 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29137295 | 1.00 | CA1 (0.61) | CA1CA2CA9CA12CA7 | |
| SCHEMBL10478711 | 1.00 | CA1 (0.61) | CA1CA2CA9CA12CA7 | |
| SCHEMBL8411185 | 1.00 | CA1 (0.61) | CA1CA2CA9CA12CA7 | |
| SCHEMBL11510742 | 1.00 | CA1 (0.61) | CA1CA2CA9CA12CA7 | |
| SCHEMBL2791299 | 0.98 | CA1 (0.60) | CA1CA2CA9CA12CA7 | |
| SCHEMBL219170 | 0.90 | — | — | |
| Fluoride SCHEMBL27620657 | 0.88 | CA1 (0.56) | CA1CA2CA9CA12CA7 | |
| SCHEMBL474049 | 0.80 | CA1 (0.67) | CA1CA2CA9CA12CA7 | |
| SCHEMBL147679 | 0.80 | CA1 (0.67) | CA1CA2CA9CA12CA7 | |
| SCHEMBL17336090 | 0.80 | CA1 (0.67) | CA1CA2CA9CA12CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070020384-A1 | Environmentally benign crop protection agents | CUTLER, ELIOT | 2007-01-25 | — | — | US | disclosed |
| US-7108861-B1 | Environmentally benign crop protection agents | CERNOFINA, LLC (US) | 2006-09-19 | — | — | US | disclosed |
| US-20010051274-A1 | Antifouling compounds and uses thereof | CERNOFINA, LLC | 2001-12-13 | — | — | US | disclosed |
| US-6307002-B1 | POLYIMIDES FROM TETRAACIDS AND DIAMINES | KANEKA CORPORATION (JP) | 2001-10-23 | — | — | US | disclosed |
| EP-1115289-A2 | ENVIRONMENTALLY BENIGN CROP PROTECTION AGENTS | Phycogen, Inc. (US) | 2001-07-18 | — | — | EP | disclosed |
| EP-1115284-A1 | ANTIFOULING AGENTS | Phycogen, Inc. (US) | 2001-07-18 | — | — | EP | disclosed |
| WO-2000016632-A2 | ENVIRONMENTALLY BENIGN CROP PROTECTION AGENTS | PHYCOGEN, INC. (US) | 2000-03-30 | — | — | WO | disclosed |
| WO-2000016623-A1 | ANTIFOULING AGENTS | PHYCOGEN, INC. (US) | 2000-03-30 | — | — | WO | disclosed |
| EP-0092830-A2 | Cephalosporin derivatives, process for their preparation, pharmaceutical compositions containing them and their application | CIBA-GEIGY AG (CH) | 1983-11-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070020384-A1 | Environmentally benign crop protection agents | CTSA, CNDP2, DDT | CA1 1599/4885CA2 1174/4885CA9 800/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.